Paeds Cases · clinical-pharmacology-and-therapeutics
Interpret and act on an out-of-range vancomycin level — OSCE
OSCE clinical-decision and communication station: interpreting an out-of-range vancomycin level in a child with serious MRSA infection, applying the area-under-the-curve target, excluding sampling and timing errors, defending the dose-adjustment plan, and explaining the plan to the nurse and family in plain language.
On this page & tools
Target exams
Candidate brief
You have eight minutes to manage a ward call about an out-of-range vancomycin level in a seven-year-old with a complicated MRSA bacteraemia. Use a structured approach: confirm the sample is valid, state the therapeutic target, decide whether to give the next dose, and propose a dose-adjustment and recheck plan. Then communicate the plan to the nurse and to the family in plain language. [1]
Key teaching and decision objectives
Confirm the sample before you act. A level can only be trusted if it was drawn at the right time, at steady state, and from the right place. Ask the nurse: was the trough drawn within 30 to 60 minutes before the next dose? Has the child reached steady state — about four to five half-lives, around the fourth dose in an older child? Was the sample drawn from a clean line and not during the infusion? Confirm the dose, the dosing interval, the time of the last dose, and the time the sample was drawn. If any of these is uncertain, repeat the level before changing the dose. [1]
State the target. For serious MRSA infection the target is the 24-hour area under the concentration–time curve over the MIC — an AUC₂₄/MIC of 400 or more — per the 2020 ASHP, IDSA, PIDS and SIDP consensus guideline. AUC-guided monitoring is preferred over a trough-only strategy because it achieves target exposure with less nephrotoxicity. A trough of 15 to 20 mg/L was a historical proxy and is imprecise; a single trough of 9 mg/L cannot, on its own, tell you whether the AUC target has been met. [1]
Decide whether to give the next dose. The child has improved clinically and the level is not toxic, so the next dose should not be withheld. The question is whether exposure is adequate, and a single trough cannot answer it. The safe next step is to give the next dose on time and move to AUC-based monitoring — either two timed levels or Bayesian forecasting from a single level. [1]
Propose the adjustment and recheck plan. Consider why the level is lower than expected. In a clinically improving child, a low trough often reflects augmented renal clearance, common in critical illness, which clears vancomycin faster than standard dosing assumes. If AUC monitoring then confirms subtherapeutic exposure, raise the dose, shorten the interval, or use a Bayesian tool, and recheck at steady state. Each day ask whether the drug is still needed and plan de-escalation once the organism and sensitivities return. [1] [2]
Communication to the nurse and family
To the nurse (plain language): "Thank you for calling. The level on its own doesn't tell us enough, so the most important thing is to give the next dose on time and let me arrange a proper area-under-the-curve check. Before we change anything, can you confirm exactly when the dose was given and when the blood was taken, and whether the sample was drawn away from the drip line. I'd rather repeat a level than change a dose on a sample we're not sure about." [1]
To the family (plain language): "Your son is getting better, which is the most important thing. We check the level of this antibiotic in his blood to make sure he's getting enough to clear the infection without too much. The number came back a little low, which can happen in a child whose body is clearing the medicine quickly. We'll give the next dose on time and do a slightly more detailed check so we can match the amount to his body. He doesn't need to stay in longer because of this — it's part of getting the dose right." [1]
Marking domains
- Clinical reasoning (30 per cent): confirms the sample is valid before acting; states the AUC₂₄/MIC of 400 target for serious MRSA; recognises that a single trough is imprecise.
- Decision-making (25 per cent): gives the next dose on time; moves to AUC-based monitoring; considers augmented renal clearance as the cause of a low level.
- Communication to the nurse (20 per cent): asks for the dose, sample and line details; explains why a repeat level is safer than a dose change; delegates safely.
- Communication to the family (15 per cent): reassures while being honest; explains the plan in plain language; avoids jargon.
- Safety and follow-up (10 per cent): arranges recheck at steady state; plans daily review and de-escalation; documents the target and review date. [1] [2] [6]
References
- [1]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review. Clin Infect Dis, 2020.PMID 32658968
- [2]He CY, Ye PP, Liu B, et al. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance. Antimicrob Agents Chemother, 2021.PMID 34339268
- [6]Jenh AM, Tamma PD, Milstone AM Extended-interval aminoglycoside dosing in pediatrics. Pediatr Infect Dis J, 2011.PMID 21407038